北アメリカの脈打たれたフィールド アブレーションの市場のサイズ 2025-2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. North America Pulsed-field Ablation Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of cardiovascular diseases driving demand for treatments.

3.2.2. Patients and healthcare providers Favor less invasive techniques, increasing demand for pulsed-field ablation.

3.2.3. Increased awareness about treatment options drives more patients to seek advanced therapies.

3.3. Key industry pitfalls & challenges

3.4.

3.4.1. The expense associated with pulsed-field ablation may limit access for some patients.

3.4.2. The need for specialized training may restrict the number of practitioners skilled in this technique.

3.4.3. accessibility Availability of alternative ablation techniques can reduce market penetration.

3.5. Market Opportunities

3.5.1. Integration with digital health solutions can enhance treatment monitoring and patient management.

3.5.2. Developing tailored treatment approaches based on individual patient profiles can improve outcomes and attract more patients.

3.5.3. Increasing efforts to educate patients about the benefits and availability of pulsed-field ablation can lead to higher adoption rates.

3.6. Porter’s Five Forces Analysis

3.7. PESTLE Analysis

3.8. Regulatory landscape

3.9. Investment Landscape

3.10. ESG Scenario

3.11. Competitive landscape

3.11.1. Company Market Share

3.11.2. Market Positioning

3.11.3. Strategy framework

3.11.4. Recent Acquisitions & Mergers

4. North America Pulsed-field Ablation Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. PFA Generators

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Catheters

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Consumables

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5. North America Pulsed-field Ablation Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Cardiology

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Oncology

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. Neurology

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.5. Dermatology

5.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Million)

6. North America Pulsed-field Ablation Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Standalone PFA Systems

6.2.1. Market Size and Forecast, 2025-2035 (USD Million)

6.3. Integrated Ablation Systems

6.3.1. Market Size and Forecast, 2025-2035 (USD Million)

6.4. AI-Assisted PFA Systems

6.4.1. Market Size and Forecast, 2025-2035 (USD Million)

7. North America Pulsed-field Ablation Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Specialty Clinics

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

7.4. Ambulatory Surgical Centers

7.4.1. Market Size and Forecast, 2025-2035 (USD Million)

7.5. Others

7.5.1. Market Size and Forecast, 2025-2035 (USD Million)

8. North America Pulsed-field Ablation Market, Region Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Region, 2025 & 2035

8.1.2. Market Revenue, By Region, 2025-2035(USD Million)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Million)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Technology, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Technology, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Technology, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. AtriCure

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. CardioFocus

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Stereotaxis

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Zyga Technology

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Nuvectra Corporation

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Endo International

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. ReCor Medical

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Triton Medical

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. ThermoGenesis Holdings

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Harrington Heart & Vascular Institute

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Medwave

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Acutus Medical

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. TAVR Medical

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Civitas Health

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Allevion

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis

9.16. Acelity

9.16.1. Business Overview

9.16.2. Financial Performance

9.16.3. Product/Service Offerings

9.16.4. Strategies & recent developments

9.16.5. SWOT Analysis